What steps is SAMHSA taking to combat the possible diversion of buprenorphine?
Larry Bucshon: “What steps is SAMHSA taking to combat the possible diversion of buprenorphine?”
Editor's note · Context
Bucshon questions SAMHSA about measures against buprenorphine diversion.
Share
More from Larry Bucshon
This amendment will provide clarity that research conducted by the Department of Defense is included in the research registration process outlined in the bill. It also requires the Office of the Inspector General at the Department of…
Again, we need to implement the HALT Fentanyl Act now. Any further delay, including the Biden administration slow- walking its implementation, is unacceptable. I again urge a ``no'' vote on this amendment, and I yield back the balance of…
One of my legislative priorities is to increase transparency and accountability in the 340B program.
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore (Mr. Valadao). The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House suspend…





